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Introduction
•

•

•

•

•

•

Dementia describes a complex syndrome arising from
abnormal brain function and impacting cognitive abilities,
decision making, and behavior (World Health Organization
[WHO], 2020).
Some causes of dementia may be reversible, if induced by
pharmacological agents, infections, or as secondary disease.
However, in many cases, dementia is progressive (WHO,
2020).

Signs and Symptoms
Cognitive domains affected (Falk et al., 2018):
•
Language
•
Complex Attention
•
Executive Function
•
Learning and Memory
•
Perceptual-Motor
•
Social Cognition
Early stage: Gradual cognitive decline. Changes include
easily dismissed memory problems (WHO, 2020).
•
Forgetfulness, such as missed appointments
or misplaced keys
•
Disorientation or getting lost in familiar
places
•
Losing track of time (WHO, 2020)
•
Intermittent difficulty remembering the
correct word or name (Alzheimer’s
Association, 2020)
•
Difficulty performing some tasks of
independent living, such as paying bills

•

Dementia is an overarching term used to refer to many
discrete causes of cognitive decline(Alzheimer’s
Association, 2020).
•
Alzheimer’s Disease
•
Lewy Body Dementia
•
Vascular Dementia
•
Frontotemporal Dementia
•
Parkinson’s and Huntington’s Dementia
•
Mixed Dementia
Dementia influences the physical, psychological, emotional,
social, and economic well-being of patients and families
(WHO, 2020). Financial costs significantly impact the
quality of life of the entire family unit and complicate to
decision making.

Middle stage: Symptoms become more evident and well
defined as dementia (WHO, 2020).
•
Behavioral changes, such as wandering,
insomnia, and repeated questioning
•
Delusional and compulsive behavior
•
Becoming lost at home (WHO, 2020)
•
Difficulty with communication and
remembering names of loved ones
•
Bowel and bladder incontinence
•
Anomic aphasia – inability to name easily
recognizable objects and their purpose
•
Difficulty with planning or completion of
daily tasks; need for assistance (WHO, 2020)

•

Dementia is currently the “fifth leading cause of death for
Americans over the age of 65,” affecting 5 million adults in
the United States and accruing $236 billion in care costs
(Falk et al. ,2018).
Worldwide incidence of dementia is expected to triple by
2050 (WHO, 2020), bringing the number of affected
American seniors to 14 million, and increasing the
American cost of dementia care to $1 trillion (Falk et al.,
2018).

•

Increasing incidence and cost adds urgency to the
development of diagnostic and treatment modalities.

•

Dementia is complex and practitioners must be educated
about all aspects of dementia care to provide effective
holistic treatment.

Pathophysiology

Late stage: Near total dependence and lack of activity.
Severe memory deficits and progression to being bedbound. Lack of awareness or acknowledgement of
surroundings (WHO, 2020).
•
Behavioral escalation including
inappropriate vocalization and aggression
(WHO, 2020)
•
Difficulty with mobility, progressing to
inability to balance well enough to stand
•
Difficulty swallowing – increasing risk for
aspiration pneumonia
•
Lack of ability to perform hygiene related
tasks (Alzheimer’s Association, 2020)

•

Figure 2. Graphic depiction of gross anatomy and histology of a normal brain and neural cells in
comparison to an Alzheimer’s affected brain and neural cells. Retrieved from
https://europepmc.org/article/PMC/6463489#free-full-text
•

Alzheimer’s Disease – exhibition of diffuse neuronal degeneration, neuroinflammation, blood brain
barrier dysfunction, and activation of glial cells (Raz et al., 2015)
•
Accumulation of extracellular senile plaques
•
Neurofibrillary tangles inside the neuron
•
Beta-amyloid peptide and tau protein are involved in neurodegeneration

•

Dementia with Lewy Bodies – vascular changes cause hypoperfusion and protein agglutination, a profound
inflammatory process occurs, and glial activation is present (Raz et al., 2015)
•
Abnormal accumulation of alpha-synuclein at synapses

•

Frontotemporal Dementia – brain atrophy and neuronal degeneration is concentrated in the frontal and
temporal lobes, glial activation is present, and aggregation of proteins is present (Raz et al., 2015)
•
Tau and ubiquitin protein aggregations are responsible for neural degeneration
•
Vascular dysfunction may play a role in disease development

•

Vascular Dementia – causes include disease of large vessels, small vessels, and cardioembolic disease;
vascular changes cause permeability of the blood brain barrier and neuronal hypoxia (Raz et al., 2015)
•
Hypertension is thought to be a risk factor
•
Lacunar infarct and white matter hyperintensities are present

•

Mixed Dementia – Alzheimer’s disease and vascular dementia are often seen as co-pathologies; unclear
which pathology is initially developed (Raz et al., 2015)
•
Beta-amyloid plaques are present in the same areas as evidence of hypoperfusion
•
Studies of mixed dementia are limited

Neuro-psychological and behavioral symptoms (Kazui et al., 2016):
•
•
•
•
•
•
Figure 1. Dementia as an overarching term. Retrieved from
https://www.alz.org/alzheimers-dementia/what-is-dementia

Agitation
Depression
Hallucinations
Anxiety
Euphoria
Apathy

•
•
•
•
•

Disinhibition
Irritability
Aberrant motor
behavior
Sleep disturbances
Eating Abnormalities

Figure 3. Magnetic resonance imaging depicting a normal control brain (A) in comparison with a brain
with Lewy Body Dementia (B) and a brain with Alzheimer’s Disease (C). Notice the relatively preserved
temporal lobes in Lewy Body Dementia. Retrieved from
https://jnnp.bmj.com/content/jnnp/86/1/50.full.pdf

Significance of Pathophysiology
All forms of dementia involve pathophysiological
processes exhibited in other diseases, such as type II
diabetes, hypertension, and obesity. By researching the
similarities present in the inflammatory reactions and
vascular degeneration of neural tissue in dementia
patients to the inflammatory markers and vascular
remodeling processes involved in other chronic illnesses,
targets for pharmacologic reversal and management may
be discovered.
In a research population observed by Clark et al.
(2020), asymptomatic adults with increased betaamyloid levels did not experience increased risk of
cognitive decline compared with the control group.
When adults with increased beta-amyloid levels were
also obese, hypertensive, or obese and hypertensive
(displaying vascular risk factors) the annual risk of
cognitive decline doubled (Clark et al., 2020). While
cognitive decline may still occur for study participants,
data indicates a potential for individuals with increased
beta-amyloid and hypertension or obesity to decline
significantly more rapidly than individuals without
vascular risk factors (Clark et al., 2020).
If a causal link is discovered between hypertension
and obesity leading to blood brain barrier dysfunction,
reduced clearance of beta-amyloid, neuronal atrophy,
and ultimately cognitive decline, early mitigation or
reversal of hypertension or obesity may slow cognitive
decline (Clark et al., 2020).
Tussing-Humphreys et al. (2020) utilized dietary
changes to manipulate cardiovascular risk factors
previously linked to obesity. Obesity correlates strongly
with cognitive decline, cognitive impairment, and
dementia (Tussing-Humphreys et al., 2020). In the
United States many adults over the age of 60 are obese
and eat a poor diet (Tussing-Humphreys et al., 2020).
Obesity, increased blood lipids, inflammatory
biomarkers, and poor glucose metabolism can all be
reversed through intentional dietary choices, avoiding
high fat, high calorie foods. In turn, risk for cognitive
decline will decrease.
Walker and Harrison (2015) researched the
significance of symptoms found in both type 2 diabetes
and Alzheimer’s disease. Specifically, cognitive deficits,
inflammation, oxidative stress, glucose intolerance, and
impaired insulin signaling/resistance appear to link
Alzheimer’s disease with type 2 diabetes (Walker &
Harrison, 2015). Impaired insulin signaling and obesity
are linked to pro-inflammatory cytokines, some of which
(tumor necrosis factor and interleukins) can cross the
blood brain barrier and affect the neural tissue. Obesity
is also associated with an increased number of
macrophages and decreased grey matter density(Walker
& Harrison, 2015). By decreasing the amount of dietary
fat consumed, inflammation is greatly decreased.
While dietary changes and decreasing inflammatory
biomarkers will not stop the pathological processes
involved in development of Alzheimer’s disease, risk
factor modification is a viable method of slowing
cognitive decline and improving quality of life.

Implications for Nursing
Care
•

As an advanced practice nurse, holistic care is
pivotal. Frequently, patients with dementia are
unaware of the implications of their diagnosis
and are left out of medical decisions (Lin,
2017). Ensuring that access to care, treatment
choices, coordination of care, and diagnostic
tests are available to patients and families
dealing with dementia allows care providers to
support the emotional and cognitive well-being
of their patients.

•

Primary care providers must be proficient in
recognizing and evaluating cognitive decline, as
patients will likely have more contact with a
primary care provider than any other care
provider (Falk et al., 2018).

•

Involving patients and caregivers in
formulating a care plan allows patients to be in
control to the extent of their cognitive abilities
(Lin, 2017).

•

Counseling/educating patients and caregivers
about modifiable risk factors and supporting
healthy changes, while prescribing
pharmacological agents as appropriate allows
families to actively embrace treatment.

Conclusions

Currently, there is no cure for dementia. Treatment
is not aimed at reversing or halting damage to
neuronal tissue. Goals of treatment include
maximizing quality of life for the patient and
caregiver, slowing disease progression, and
modifying risk factors as possible. Advanced
practice nurses are poised to change lives through
early diagnosis and holistic dementia care.
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